EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.409
https://www.valueinhealthjournal.com/article/S1098-3015(22)00610-6/fulltext
Title :
EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00610-6&doi=10.1016/j.jval.2022.04.409
First page :
Section Title :
Open access? :
No
Section Order :
10361